Shiny K. Kajal/LinkedIn
Mar 3, 2026, 17:04
Shiny K Kajal: Therapeutic Apheresis Is Redefining the Clinical Scope of Transfusion Medicine
Shiny K Kajal, Senior Resident at Adesh University, shared a post on LinkedIn:
“Post 29 – When most people think of transfusion medicine, they think of blood bags and compatibility testing.
But modern Immunohematology and Blood Transfusion goes far beyond that.
Therapeutic Apheresis allows selective removal of disease-causing components directly from circulation – offering rapid clinical benefit in several critical conditions.
Key Apheresis Modalities
- Therapeutic Plasma Exchange (TPE) – Removal of pathogenic plasma components
- Red Cell Exchange – Replacement of abnormal erythrocytes
- Leukapheresis – Rapid cytoreduction in leukocytosis
- Plateletpheresis – Control of extreme thrombocytosis
- LDL Apheresis – Removal of atherogenic lipoproteins
From autoimmune diseases to hematologic emergencies, therapeutic apheresis is redefining the clinical scope of transfusion medicine.
Not just transfusing blood — but therapeutically transforming it.”
Stay updated with Hemostasis Today.
-
Apr 20, 2026, 15:31Tzu-Fei Wang: Drug–Drug Interactions Between DOACs and Prostate Cancer Therapies
-
Apr 20, 2026, 15:30Abinash Choudhury: A Mother’s Advocacy Transforming Hemophilia Care in Nigeria
-
Apr 20, 2026, 15:30Kalyan Roy: A Critical Safety Intervention in Transfusion Medicine
-
Apr 20, 2026, 15:23Bruno Lacombe: Experiencing a “A Life in a Day” with Hemophilia in Japan
-
Apr 20, 2026, 15:20Eman Hassan: New Insight into AF and VTE at BSH 2026
-
Apr 20, 2026, 15:12Tushar Pandey: From ITP to TTP in Clinical Practice
-
Apr 20, 2026, 15:03Wolfgang Miesbach: The Most Underappreciated Challenges in Haemophilia Care Tackled at WFH 2026
-
Apr 20, 2026, 15:03Danielle Boyle: Patient Voices Transform Progress in ITP Research and Care with ISTH
-
Apr 20, 2026, 14:48Melissa Hollo: Intravenous Iron Shows Better Results Than Oral Iron in Pregnancy